# FDA Inspection 1002170 - Biomat USA Inc - February 15, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/dded0501-6046-405c-8c3d-5c22b72ea6cd
Source feed: FDA_Inspections

> FDA Inspection 1002170 for Biomat USA Inc on February 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002170
- Company Name: Biomat USA Inc
- Inspection Date: 2017-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1082533 - 2019-03-14](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c4914351-cfb9-405c-a6b8-44b454c1c888)
- [FDA Inspection 925809 - 2015-05-08](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/d7042f07-db5e-4b3f-a2b0-7d099e6b1721)
- [FDA Inspection 812446 - 2012-12-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c2d02bac-a0f4-4cd2-b446-4ce7e490519c)
- [FDA Inspection 563661 - 2009-01-28](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/1f24eff5-d5ba-4275-8b85-409ac8e14389)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/98944397-cd4f-40dc-bcd7-f0a62b2a7cc3

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d